Global Biotech Stocks

Senti Biosciences

Market Cap: US$36.9m

A clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases.

Nectar Lifesciences

Market Cap: ₹3.2b

Manufactures, distributes, markets and sells pharmaceutical products in India and internationally.

Mural Oncology

Market Cap: US$36.2m

Operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer.

Akari Therapeutics

Market Cap: US$36.2m

An oncology company, develops next-generation antibody-drug conjugates (ADC) for cancer-killing toxins.

G.F.C Green Fields Capital

Market Cap: ₪121.3m

Does not have significant operations.

NeuroScientific Biopharmaceuticals

Market Cap: AU$54.9m

Engages in the research and development of novel peptide-based pharmaceutical products.

Bioqual

Market Cap: US$35.8m

Provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States.

Mendus

Market Cap: SEK 332.3m

A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.

Rhone Ma Holdings Berhad

Market Cap: RM 147.6m

An investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia.

AN2 Therapeutics

Market Cap: US$34.8m

A biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics.

Nicox

Market Cap: €29.8m

Operates as an ophthalmology company in France and internationally.

Korean Drug

Market Cap: ₩48.9b

Manufactures and sells medicines for treating various diseases in South Korea.

Biotoxtech

Market Cap: ₩48.7b

Engages in the safety evaluation of synthetic medicines, biomedicines, cell therapy products, gene therapy products, health functional foods, chemicals, and pesticides in South Korea.

OnKure Therapeutics

Market Cap: US$34.4m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers.

Eusol BiotechLtd

Market Cap: NT$1.0b

Focuses on research and development of new biotech drugs for sleep disorders.

Cynata Therapeutics

Market Cap: AU$52.2m

Engages in the development and commercialization of proprietary induced pluripotent stem cell and mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia.

Labiana Health

Market Cap: €28.6m

Develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, and internationally.

Aligned Genetics

Market Cap: ₩47.0b

Offers cellular imaging and biomolecular analysis solutions worldwide.

Poltreg

Market Cap: zł120.8m

A biotechnology company, researches and develops therapies for autoimmune diseases.

LakeShore Biopharma

Market Cap: US$33.0m

A biopharmaceutical company, discovers, develops, manufactures, commercializes, and sells vaccines and therapeutic biologics for infectious diseases and cancer.

Kyung Nam PharmLtd

Market Cap: ₩46.4b

Engages in the manufacture and sale of pharmaceutical, cosmetic, chemical, and health functional food products in South Korea, North America, and rest of Asia.

Cyfuse Biomedical K.K

Market Cap: JP¥4.9b

Engages in the development, manufacture, and sale of regenerative medicine products in Japan.

Natural Capsules

Market Cap: ₹2.8b

Engages in manufacture and sale of hard gelatin and cellulose capsule shells in India and internationally.

Revium Rx

Market Cap: US$31.6m

A pre-clinical stage biopharmaceutical company, develops nano-liposomal particles (NLP) based pharmaceutical candidates.

CORESTEMCHEMON

Market Cap: ₩43.8b

A bio-pharmaceutical company, engages in the development and production of stem cell therapies for the treatment of incurable diseases in South Korea.

NGeneBio

Market Cap: ₩43.0b

Develops in vitro diagnostics companion diagnostics products and bioinformatics software.

Gennex Laboratories

Market Cap: ₹2.7b

Manufactures and sells bulk drugs, intermediates, and biotech products.

Immuno-Biological Laboratories

Market Cap: JP¥4.5b

Engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide.

NeuroSense Therapeutics

Market Cap: US$29.6m

A clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally.

Rubicon Organics

Market Cap: CA$41.0m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

Biotechnology Assets

Market Cap: €25.0m

Develops and markets biotechnological assets for application in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industry sectors in Spain and internationally.

Yung Zip Chemical Ind

Market Cap: NT$889.8m

Yung Zip Chemical Ind. Co., Ltd., manufacturing, trading and sale of pharmaceuticals, pharmaceuticals, agricultural and industrial drugs, APIs, specialty chemicals and other related products internationally.

Ambalal Sarabhai Enterprises

Market Cap: ₹2.6b

Manufactures, markets, and supplies pharmaceutical products in India and internationally.

Ribomic

Market Cap: JP¥4.3b

Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan.

FLUENT

Market Cap: US$28.7m

Through its subsidiaries, cultivates, manufactures processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas.

Advicenne

Market Cap: €24.5m

A specialty pharmaceutical company, develops, commercializes, and markets treatments for rare renal diseases in France and internationally.